Chanakya Kodishala

One of Dr. Kodishala's most prominent areas of study is examining how Rheumatoid Arthritis (RA) affects the brain. Historically, RA was viewed primarily as a joint disease. However, work co-authored by Dr. Kodishala emphasizes that systemic inflammation can accelerate cognitive decline.

Beyond his work in the United States, Chanakya Kodishala has contributed to studies within the Indian rheumatology community. He was part of a major collaborative study assessing the risk factors associated with COVID-19 in systemic lupus erythematosus (SLE) patients.

: He has published on how a high "multimorbidity burden" (having multiple medical comorbidities) can predict a lower likelihood of disease remission and a higher risk of flares in arthritis patients .

Dr. Kodishala appears as an active member of professional bodies, being listed as an author on presentations and papers for organizations like the and the Indian Journal of Rheumatology . Chanakya Kodishala

His primary research has centered on understanding the long-term neurological and systemic complications in patients with Rheumatic Diseases. Specifically, his work has focused on:

Chanakya Kodishala is more than a name on a movie poster’s credit roll. He is a case study in how to turn fandom into a profession. In an era where attention is the most expensive currency, he acts as the chief economist, spending that currency wisely to create cultural moments.

Dr. Kodishala has engaged in complex statistical modeling—such as mediation analysis—to understand how RA triggers cognitive decline. In a prominent study examining the impact of cardiovascular and cerebrovascular disease on dementia risk , he and his team broke down the structural pathways of brain injury. Through the neuropathologic evaluation of tissue, his work demonstrated that cerebrovascular damage frequently serves as the mediating link between chronic, uncontrolled joint inflammation and neurodegenerative outcomes. 3. Autoimmune Vulnerabilities During the Pandemic One of Dr

As of the current fiscal year, Chanakya Kodishala is believed to be associated with a high-growth B2B fintech platform focusing on . The manufacturing sector in Tier-2 cities (like Coimbatore, Jaipur, and Indore) struggles with cash flow due to 60-90 day payment cycles from large buyers.

about his collaboration on COVID-19 and Lupus? pmc.ncbi.nlm.nih.gov

“We don’t do psychographics,” he says firmly. “We don’t need to know if you are neurotic or agreeable. That is pseudoscience. We need to know if your paddy was harvested late. That is economics.” However, work co-authored by Dr

A: He is best known for his work in B2B digital lending infrastructure, specifically creating APIs for embedded finance and alternative credit scoring models for India’s MSME sector.

in Ohio and previously served as a postdoctoral research fellow at the Mayo Clinic in Rochester, Minnesota. Early Education and Career